Free Trial

MetLife (MET) Competitors

MetLife logo
$80.81 -0.31 (-0.38%)
Closing price 03:59 PM Eastern
Extended Trading
$81.38 +0.57 (+0.71%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MET vs. AFL, AIZ, AMP, CNO, EQH, ORI, PFG, PRU, RDN, and UNM

Should you be buying MetLife stock or one of its competitors? The main competitors of MetLife include Aflac (AFL), Assurant (AIZ), Ameriprise Financial (AMP), CNO Financial Group (CNO), Equitable (EQH), Old Republic International (ORI), Principal Financial Group (PFG), Prudential Financial (PRU), Radian Group (RDN), and Unum Group (UNM). These companies are all part of the "finance" sector.

MetLife vs. Its Competitors

MetLife (NYSE:MET) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

MetLife pays an annual dividend of $2.27 per share and has a dividend yield of 2.8%. Aflac pays an annual dividend of $2.32 per share and has a dividend yield of 2.2%. MetLife pays out 38.5% of its earnings in the form of a dividend. Aflac pays out 52.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MetLife has raised its dividend for 12 consecutive years and Aflac has raised its dividend for 44 consecutive years. MetLife is clearly the better dividend stock, given its higher yield and lower payout ratio.

MetLife presently has a consensus target price of $95.60, indicating a potential upside of 18.31%. Aflac has a consensus target price of $109.15, indicating a potential upside of 2.85%. Given MetLife's stronger consensus rating and higher probable upside, equities analysts clearly believe MetLife is more favorable than Aflac.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MetLife
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91
Aflac
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

In the previous week, Aflac had 2 more articles in the media than MetLife. MarketBeat recorded 35 mentions for Aflac and 33 mentions for MetLife. MetLife's average media sentiment score of 1.15 beat Aflac's score of 1.02 indicating that MetLife is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MetLife
21 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive
Aflac
23 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aflac has a net margin of 15.32% compared to MetLife's net margin of 5.83%. MetLife's return on equity of 19.88% beat Aflac's return on equity.

Company Net Margins Return on Equity Return on Assets
MetLife5.83% 19.88% 0.82%
Aflac 15.32%15.08%3.21%

MetLife has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Aflac has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Aflac has lower revenue, but higher earnings than MetLife. MetLife is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MetLife$70.99B0.76$4.43B$5.9013.70
Aflac$18.93B3.00$5.44B$4.4124.07

95.0% of MetLife shares are held by institutional investors. Comparatively, 67.4% of Aflac shares are held by institutional investors. 0.4% of MetLife shares are held by insiders. Comparatively, 0.9% of Aflac shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

MetLife beats Aflac on 11 of the 19 factors compared between the two stocks.

Get MetLife News Delivered to You Automatically

Sign up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MET vs. The Competition

MetricMetLifeINS IndustryFinance SectorNYSE Exchange
Market Cap$53.94B$21.09B$12.54B$21.32B
Dividend Yield2.80%2.66%5.43%3.51%
P/E Ratio13.7014.0419.4329.34
Price / Sales0.762.1126.3552.89
Price / Cash11.3017.4622.1723.86
Price / Book1.922.112.365.39
Net Income$4.43B$1.62B$1.01B$996.59M
7 Day Performance2.10%-1.03%2.27%3.12%
1 Month Performance4.08%3.18%2.27%2.97%
1 Year Performance6.67%17.88%540.60%12.83%

MetLife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MET
MetLife
4.9926 of 5 stars
$80.81
-0.4%
$95.60
+18.3%
+8.2%$53.94B$70.99B13.7045,000Trending News
AFL
Aflac
4.7374 of 5 stars
$105.77
+0.4%
$109.15
+3.2%
-0.1%$56.57B$18.93B23.9812,694Positive News
AIZ
Assurant
4.9088 of 5 stars
$209.53
-1.4%
$233.29
+11.3%
+11.3%$10.57B$11.88B15.1714,200Positive News
Analyst Revision
AMP
Ameriprise Financial
4.5942 of 5 stars
$505.19
+0.4%
$534.71
+5.8%
+18.1%$47.62B$17.26B15.7213,600Positive News
CNO
CNO Financial Group
4.8058 of 5 stars
$37.75
+0.3%
$43.40
+15.0%
+17.0%$3.66B$4.45B13.933,500Positive News
EQH
Equitable
3.2723 of 5 stars
$53.05
-1.6%
$64.90
+22.3%
+28.5%$15.89B$12.44B42.798,000Positive News
ORI
Old Republic International
4.1091 of 5 stars
$38.07
-1.4%
$41.50
+9.0%
+14.0%$9.46B$8.67B13.049,400Positive News
Insider Trade
PFG
Principal Financial Group
3.9003 of 5 stars
$77.70
+0.1%
$86.90
+11.8%
+1.7%$17.31B$15.13B11.6319,300Positive News
PRU
Prudential Financial
4.8992 of 5 stars
$106.66
+0.7%
$122.08
+14.5%
-7.1%$37.55B$68.05B23.6538,196Positive News
Analyst Revision
RDN
Radian Group
2.6739 of 5 stars
$34.35
-0.5%
$37.00
+7.7%
-2.0%$4.65B$1.29B8.651,400Positive News
Ex-Dividend
UNM
Unum Group
4.9896 of 5 stars
$68.57
-0.4%
$91.15
+32.9%
+27.1%$11.68B$12.89B8.2011,063News Coverage
Positive News

Related Companies and Tools


This page (NYSE:MET) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners